By Mill Chart
Last update: Nov 23, 2022
The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today.
Ticker | Change | Comment |
---|---|---|
TNYA | 14.75% | TENAYA THERAPEUTICS INC's (NASDAQ:TNYA) shares rose 14.75% to $2.8. In the last 3 months the share price dropped with 44.67%. |
REVB | 9.52% | REVELATION BIOSCIENCES INC's (NASDAQ:REVB) stock price increased by 9.52% to $0.23. Shareholders saw the stock price going 34.02% lower in the past month. |
AEI | 8.64% | ALSET INC (NASDAQ:AEI) rose 8.64% to $0.24 during Wednesday's after hours session. This is a continuation of today's gain of 10.83%. NASDAQ:AEI released their earnings today. |
HGEN | 7.14% | HUMANIGEN INC's (NASDAQ:HGEN) shares rose 7.14% to $0.15. In the last 3 months the stock lost 48.77%. |
EQRX | 4.87% | EQRX INC's (NASDAQ:EQRX) shares rose 4.87% to $3.66. In the last month the stock lost 32.76%. |
RKLB | 4.77% | ROCKET LAB USA INC's (NASDAQ:RKLB) shares rose 4.77% to $4.61 during Wednesday's after hours session. Earlier today the company had a press release: NASA Selects Rocket Lab to Launch TROPICS Mission. |
BSGM | 4.77% | BIOSIG TECHNOLOGIES INC's (NASDAQ:BSGM) shares rose 4.77% to $0.4 during Wednesday's after hours session. The stock is trading 23.69% lower than a month ago. |
BTCM | 4.76% | BIT MINING LTD - SPON ADR's (NYSE:BTCM) shares rose 4.76% to $0.22. In the last 3 months the stock lost 46.75%. |
NEXI | 4.55% | NEXIMMUNE INC's (NASDAQ:NEXI) stock price is advancing with 4.55% to a price of $0.46. In the last month the stock lost 31.39%. |
EDIT | 4.53% | EDITAS MEDICINE INC's (NASDAQ:EDIT) shares rose 4.53% to $10.84 during Wednesday's after hours session. In the last 3 months the stock lost 30.07%. |
For the full after hours gainers list go to our after hours gainers screener.
Ticker | Change | Comment |
---|---|---|
COSM | -13.12% | COSMOS HOLDINGS INC's (NASDAQ:COSM) shares fell 13.12% to $0.28. The company released earnings today. In the last month the stock gained 187.0%. |
LU | -6.86% | LUFAX HOLDING LTD-ADR's (NYSE:LU) stock price is declining with 6.86% to a price of $1.63. LUFAX HOLDING LTD-ADR released earnings Yesterday. Shareholders saw the stock price going 59.95% lower in the past 3 months. |
CNEY | -6.21% | CN ENERGY GROUP INC-A's (NASDAQ:CNEY) shares fell 6.21% to $1.66. The stock is trading 25.63% lower than 6 months ago. |
GAU | -5.0% | GALIANO GOLD INC's (NYSEARCA:GAU) shares fell 5.0% to $0.57. In the last 3 months the stock gained 22.25%. |
GROY | -4.88% | GOLD ROYALTY CORP's (NYSEARCA:GROY) shares fell 4.88% to $2.73 during Wednesday's after hours session. In the last year the stock lost 43.73%. |
JFU | -4.76% | 9F INC - ADR's (NASDAQ:JFU) stock price is declining with 4.76% to a price of $0.2. After today's gain of 10.53%, it goes down with 4.76% in today's after hours session. |
CYBN | -4.65% | CYBIN INC's (NYSEARCA:CYBN) shares fell 4.65% to $0.41 during Wednesday's after hours session. The stock is trading 57.43% lower than 3 months ago. |
VZIO | -4.13% | VIZIO HOLDING CORP-A's (NYSE:VZIO) shares fell 4.13% to $10.22. Two days ago the company had a press release: CORRECTING and REPLACING VIZIO Black Friday Deals: Celebrate Holiday Savings on Award-Winning TVs and Sound Bars. |
KAL | -4.04% | KALERA PLC's (NASDAQ:KAL) stock price is declining with 4.04% to a price of $0.15. After running up 76.92% in today's session, NASDAQ:KAL is pulling back after hours. |
SENS | -3.44% | SENSEONICS HOLDINGS INC's (NYSEARCA:SENS) shares fell 3.44% to $1.12. The stock is trading 35.2% lower than 3 months ago. |
Our after hours losers screener will show you the full list.
EDITAS MEDICINE INC
NASDAQ:EDIT (5/17/2024, 7:00:01 PM)
After market: 5.7592 +0.14 (+2.48%)5.62
-0.27 (-4.58%)
CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that...
Research includes the first-ever application of AsCas12a in vivo, optimized LNP delivery, and gene editing RNA guide modifications Data to support...
The company has great potential if and when it enters the commercial stage.
EDIT stock results show that Editas Medicine missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that it...
Two-year extension for research and development of alpha-beta T cell medicines for the treatment of cancer and autoimmune diseases
Two-year extension for research and development of alpha-beta T cell medicines for the treatment of cancer and autoimmune diseases...